<ruby id="iksgg"></ruby>
<em id="iksgg"><object id="iksgg"><u id="iksgg"></u></object></em>
<dd id="iksgg"></dd><em id="iksgg"></em>

    <th id="iksgg"><pre id="iksgg"></pre></th>

    <em id="iksgg"><acronym id="iksgg"></acronym></em>
    <button id="iksgg"></button>

    <button id="iksgg"></button>

      <progress id="iksgg"><track id="iksgg"></track></progress>
      <button id="iksgg"><acronym id="iksgg"></acronym></button>
    1. <rp id="iksgg"><ruby id="iksgg"><input id="iksgg"></input></ruby></rp>

      Chengdu's HitGen to Collaborate with Global Blood Therapeutics
      Author:Yestar      Time:2016-01-12
      HitGen Ltd, a Chengdu CRO specializing in drug discovery, formed a research collaboration with Global Blood Therapeutics of the US, a clinical-stage biopharma focused on therapeutics for blood-based disorders. HitGen will provide biology, chemistry, and screening on an undisclosed novel GBT target. GBT's lead molecule is a clinical-stage drug candidate that treats the underlying mechanism of sickle cell disease, which was recently granted Orphan Drug designation in the US.

      Copyright ? 2017 Yestar Healthcare Holdings Company Limited     Powered By : Yestarcorp    滬ICP備10207132號-5

        滬公網安備 31011202004160號
      最近更新中文字幕免费 久久爱www人成狠狠爱综合网| 精品国精品国产自在久国产| 真实播放国产乱子伦视频| 欧美free嫩交hd| 国产精品超清白人精品av| 国产高清自产拍av在线| 真实播放国产乱子伦视频| 特大巨黑吊av在线播放| 国产欧美另类久久久精品图片| 黃色a片三級三級三級| 天天做天天爱天天综合网|